Hongling Zhao
-
- Cancer-related Molecular Pathways 11
-
- Venous Thromboembolism Diagnosis and Management 2
-
- Ubiquitin and proteasome pathways 7
-
- Acute Ischemic Stroke Management 4
-
- Cerebrovascular and Carotid Artery Diseases 3
- Sarcoma Diagnosis and Treatment 3
- Cardiovascular and Diving-Related Complications 2
-
- Microtubule and mitosis dynamics 2
- Co-authors
- Liang ZhuZhonglei LuFrederick BauzonHao FuJinhua CuiKeiko NakayamaKeiichi I. NakayamaJoseph Locker
- Journals
- Journal of Biological Chemistry (2 papers)Nature Communications (1 paper)The EMBO Journal (1 paper)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Hongling Zhao
31 papers receiving 408 citations
Peers
Comparison fields: 5 of 76
- Oncology 159
- Biological Psychiatry 11
- Internal Medicine 16
- Molecular Biology 225
- Cancer Research 38
Countries citing papers authored by Hongling Zhao
This map shows the geographic impact of Hongling Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongling Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongling Zhao more than expected).
Fields of papers citing papers by Hongling Zhao
This network shows the impact of papers produced by Hongling Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongling Zhao. The network helps show where Hongling Zhao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hongling Zhao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 9 | |
| 6 | 2024 | 3 | |
| 7 | 2023 | 1 | |
| 8 | 2021 | 7 | |
| 9 | 2020 | 28 | |
| 10 | 2020 | 17 | |
| 11 | 2019 | 20 | |
| 12 | 2018 | 1 | |
| 13 | 2017 | 23 | |
| 14 | 2016 | 9 | |
| 15 | 2015 | 11 | |
| 16 | 2014 | 38 | |
| 17 | 2013 | 63 | |
| 18 | 2009 | 37 | |
| 19 | A robust multigene expression assay to predict clinical response to chemoradiotherapy | 2008 | 1 |
| 20 | 2007 | 2 |
About Hongling Zhao
Hongling Zhao is a scholar working on Oncology, Internal Medicine and Pulmonary and Respiratory Medicine, having authored 35 papers that have together received 408 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (11 papers), Ubiquitin and proteasome pathways (7 papers), Acute Ischemic Stroke Management (4 papers), Cerebrovascular and Carotid Artery Diseases (3 papers), Sarcoma Diagnosis and Treatment (3 papers), Microtubule and mitosis dynamics (2 papers), Cardiovascular and Diving-Related Complications (2 papers) and Venous Thromboembolism Diagnosis and Management (2 papers). The work is most often cited by research in Oncology (159 citations), Biological Psychiatry (11 citations) and Internal Medicine (16 citations). Hongling Zhao has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Liang Zhu, Zhonglei Lu, Frederick Bauzon, Hao Fu, Jinhua Cui, Keiko Nakayama, Keiichi I. Nakayama, Joseph Locker, Edward L. Schwartz and Bao‐Xiang Zhao. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.